Last reviewed · How we verify

Ceftriaxon — Competitive Intelligence Brief

Ceftriaxon (Ceftriaxon) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Immunology.

marketed Alpha-synuclein, D-amino-acid oxidase, Penicillin-binding protein 1A Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Ceftriaxon (Ceftriaxon) — Centre Hospitalier Universitaire Vaudois.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ceftriaxon TARGET Ceftriaxon Centre Hospitalier Universitaire Vaudois marketed Alpha-synuclein, D-amino-acid oxidase, Penicillin-binding protein 1A
Rocephin ceftriaxone Generic (originally Roche) marketed Cephalosporin antibiotic (third-generation) Alpha-synuclein, D-amino-acid oxidase, Penicillin-binding protein 1A 1984-12-21

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ceftriaxon — Competitive Intelligence Brief. https://druglandscape.com/ci/ceftriaxon. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: